Urgent.News

What's breaking now, across thousands of outlets.

World

Man referred to prosecution on suspicion of killing teen victim of son's alleged sex crime

Police on Friday referred a man to the prosecution on suspicion of killing a teenage girl alleged to have been sexually assaulted by his son, officials said. The 59-year-old was referred to the Seoul Northern District Prosecutors Office, according to the Seoul Seongbuk Police Station. During questioning, the suspect said he killed the teenager on impulse out of anger while asking her to submit a…

Man referred to prosecution on suspicion of killing teen victim of son's alleged sex crime

On Friday, police referred a 59-year-old man to prosecutors on suspicion of killing a teenage girl, according to officials. The suspect was allegedly involved in a sexual assault on the victim, which prosecutors claim occurred in January, according to Seoul Seongbuk Police Station.

During questioning, the man claimed he killed the teenager in a fit of anger, requesting her to sign a statement denying her desire for his son to face punishment, police said. The man was under emergency arrest last week after the victim's body was discovered at an Airbnb property in Seoul's Seongbuk Ward, with the suspect reportedly intoxicated at the time, officials said.

The victim's parents had filed a complaint in March against the suspect's son, alleging that he had sexual relations with their daughter, according to local reports. The son is currently in detention for another crime.

Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at koreatimes.co.kr →

More in World

German Court Overturns Keytruda SC Sales Ban, Opening Door to European Expansion

The path to market entry in Germany, Europe’s largest pharmaceutical market, has opened for Keytruda SC, the subcutaneous formulation of the immuno-oncology drug developed by U.S.-based Merck (MSD)…

  • German court overturns ban on Keytruda SC sales, allowing European expansion.
  • Merck wins patent disputes in Germany and U.S., clearing path for drug's entry.
  • Keytruda SC's subcutaneous formulation reduces treatment time to one to two minutes.

More from Friday 20 November →